Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bingrui Li
Observed name:
B. Li
Institutions:
Xinjiang Medical University,
Second Military Medical University
Observed institutions:
Centers for Disease Control and Prevention,
Army Medical University,
Xinjiang Medical University,
Second Military Medical University,
University of Kansas Medical Center,
Southwest Hospital
show all 6
ORCID:
0009-0009-1693-0820
Observed ORCID:
0009-0009-1693-0820
OpenAlex ID:
A5025986157
Interleukin-1 receptor associated kinases-1/4 inhibition protects against acute hypoxia/ischemia-induced neuronal injury in vivo and in vitro
2011
·
Y.-F. Yang
, Z. Chen
, et al.
·
Neuroscience
·
34
Functional gold nanoparticles in diagnosis and treatment of cancer: A systematic review
2025
·
Bingrui Li
, Maihemuti Yakufu
, et al.
·
APL Materials
·
12
Analysis of true voluntary blood donors with anti‐HCV prevalence and implications for donor management in Chongqing, China
2007
·
S. M. Zhao
, T. L. Jiang
, et al.
·
Transfusion Medicine
·
9
Effects of polycystic ovary syndrome on liver, heart, muscle, and pancreatic-related diseases
2026
·
Bingrui Li
, Yuan Li
, et al.
·
Frontiers in Endocrinology
·
5
PDF
Engineering upconversion nanoparticles for synergistic photodynamic, photothermal and chemotherapy
2026
·
Chenkun Gao
, Bingrui Li
, et al.
·
Nanoscale
Study of DNA Delivery with PLGA Nanoparticle Promoted by Ultrasound in vivo of the Prostate Cancer
2011
·
H. Zhang
, Y. Li
, et al.
·
Ultrasound in Medicine & Biology
Show more works
View as search
Works count:
6
Citation count:
60
H-index:
4
I10-index:
2
Year
Topic
Type